Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
28.60
-0.07 (-0.24%)
At close: May 14, 2026, 4:00 PM EDT
28.60
0.00 (0.00%)
After-hours: May 14, 2026, 4:16 PM EDT
Legend Biotech Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$62.08
Upside
+117.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $21 → $29 | Hold | Maintains | $21 → $29 | +1.40% | May 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $49 → $48 | Buy | Maintains | $49 → $48 | +67.83% | May 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $62 → $64 | Buy | Maintains | $62 → $64 | +123.78% | May 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +74.83% | Apr 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +74.83% | Apr 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $49 | Buy | Maintains | $50 → $49 | +71.33% | Mar 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $66 → $62 | Buy | Maintains | $66 → $62 | +116.78% | Mar 11, 2026 |
| Barclays | Barclays | Buy Maintains $90 → $80 | Buy | Maintains | $90 → $80 | +179.72% | Feb 4, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +74.83% | Jan 22, 2026 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades $62 → $21 | Strong Buy → Hold | Downgrades | $62 → $21 | -26.57% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $66 | Buy | Maintains | $66 | +130.77% | Jan 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $75 | Buy | Initiates | $75 | +162.24% | Jan 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $75 → $74 | Buy | Maintains | $75 → $74 | +158.74% | Dec 17, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $83 → $50 | Buy | Maintains | $83 → $50 | +74.83% | Dec 12, 2025 |
| UBS | UBS | Strong Buy Maintains $54 → $48 | Strong Buy | Maintains | $54 → $48 | +67.83% | Dec 8, 2025 |
| Barclays | Barclays | Buy Maintains $94 → $90 | Buy | Maintains | $94 → $90 | +214.69% | Nov 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.